Researchers devise more efficient, enduring CAR gene therapy to combat HIV

UCLA RESEARCH BRIEF
T cell infected with HIV
The improved therapy engineers the body’s immune response against HIV rather than waiting for the virus — or parts of the virus — to induce a response. (Image: A T cell infected with HIV.)

Related Content

Articles:

Media Contact

Enrique Rivero
310-267-7120
erivero@mednet.ucla.edu
Share: